Prevention of infectious complications in peritoneal dialysis: best demonstrated practices
- PMID: 17080111
- DOI: 10.1038/sj.ki.5001915
Prevention of infectious complications in peritoneal dialysis: best demonstrated practices
Abstract
Peritoneal dialysis (PD) related infections continue to be a serious complication for PD patients. Peritonitis can be associated with pain, hospitalization and catheter loss as well as a risk of death. Peritonitis risk is not evenly spread across the PD population or programs. Very low rates of peritonitis in a program are possible if close attention is paid to the causes of peritonitis and protocols implemented to reduce the risk of infection. Protocols to decrease infection risk in PD patients include proper catheter placement, exit-site care that includes Staphylococcus aureus prophylaxis, careful training of patients with periodic retraining, treatment of contamination, and prevention of procedure-related and fungal peritonitis. Extensive data have been published on the use of antibiotic prophylaxis to prevent exit site infections. There are fewer data on training methods of patients to prevent infection risk. Quality improvement programs with continuous monitoring of infections, both of the catheter exit site and peritonitis, are important to decrease the PD related infections in PD programs. Continuous review of every episode of infection to determine the root cause of the event should be routine in PD programs. Further research is needed examining approaches to decrease infection risk.
Similar articles
-
A contemporary approach to the prevention of peritoneal dialysis-related peritonitis in children: the role of improvement science.Pediatr Nephrol. 2017 Aug;32(8):1331-1341. doi: 10.1007/s00467-016-3531-1. Epub 2016 Oct 18. Pediatr Nephrol. 2017. PMID: 27757588 Review.
-
Prevention of peritonitis in children: emerging concepts.Perit Dial Int. 2009 Feb;29 Suppl 2:S186-9. Perit Dial Int. 2009. PMID: 19270214 Review.
-
Amuchina 10% solution, safe antiseptic for preventing infections of exit-site of Tenckhoff catheters, in the pediatric population of a dialysis program.Contrib Nephrol. 2007;154:139-144. doi: 10.1159/000096959. Contrib Nephrol. 2007. PMID: 17099309 Clinical Trial.
-
Peritoneal dialysis-related infections recommendations: 2010 update. What is new?Int Urol Nephrol. 2012 Apr;44(2):593-600. doi: 10.1007/s11255-011-9995-9. Epub 2011 Jul 9. Int Urol Nephrol. 2012. PMID: 21744125 Review.
-
Staphylococcal infections in PD: monitoring, screening and prevention.EDTNA ERCA J. 2005 Jan-Mar;31(1):10-2. doi: 10.1111/j.1755-6686.2005.tb00381.x. EDTNA ERCA J. 2005. PMID: 16083019
Cited by
-
The association between exit site infection and subsequent peritonitis among peritoneal dialysis patients.Clin J Am Soc Nephrol. 2012 Aug;7(8):1266-71. doi: 10.2215/CJN.00980112. Epub 2012 Jun 28. Clin J Am Soc Nephrol. 2012. PMID: 22745277 Free PMC article. Clinical Trial.
-
Statin therapy in peritoneal dialysis patients: effects beyond lipid lowering.Int Urol Nephrol. 2008;40(1):165-70. doi: 10.1007/s11255-007-9307-6. Epub 2007 Dec 8. Int Urol Nephrol. 2008. PMID: 18066677 Review.
-
Key factors for a high-quality peritoneal dialysis program--the role of the PD team and continuous quality improvement.Perit Dial Int. 2014 Jun;34 Suppl 2(Suppl 2):S35-42. doi: 10.3747/pdi.2013.00120. Perit Dial Int. 2014. PMID: 24962961 Free PMC article. Review.
-
Peritonitis in recent years: clinical findings and predictors of treatment response of 170 episodes at a single Brazilian center.Int Urol Nephrol. 2012 Oct;44(5):1529-37. doi: 10.1007/s11255-011-0107-7. Int Urol Nephrol. 2012. PMID: 22302733
-
Sevelamer use and incidence of peritonitis in peritoneal dialysis.Wien Klin Wochenschr. 2011 Apr;123(7-8):204-8. doi: 10.1007/s00508-011-1551-1. Epub 2011 Mar 28. Wien Klin Wochenschr. 2011. PMID: 21442203
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical